BAI Xiao-jun, REN Jian-xun. The Treatment of No-reflow Occurring During Percutaneous Coronary Intervention on the Pathogenesis of Insidious Phlegm[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 237-240.
DOI:
BAI Xiao-jun, REN Jian-xun. The Treatment of No-reflow Occurring During Percutaneous Coronary Intervention on the Pathogenesis of Insidious Phlegm[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 237-240. DOI: 10.13422/j.cnki.syfjx.2014160237.
The Treatment of No-reflow Occurring During Percutaneous Coronary Intervention on the Pathogenesis of Insidious Phlegm
Myocardial no-reflow phenomenon still have induced the incidence of major cardiovascular events after percutaneous coronary intervention in patients with acute myocardial infarction and can severe affect the prognosis
and its pathological proecsses includes vascular endothelial injury
inflammatiory reaction
oxygen free radical damage and platelet activation
etc. Although many drugs have been studied for intervention of specific pathological proecsses in no-reflow phenomenon
the effects were rarely observed because of its single target intervention. So it is urgent to resolve that how to improve blood flow perfusion of myocardium microcirculation after revascularization for acute myocardial infarction. Traditional Chinese medicines have been taken on significant effects on myocardial no-reflow phenomenon although few reports are showed. We deduced that insidious phlegm blocking collaterals was the major pathogenesis of myocardial no-reflow phenomenon after myocardial ischemia reperfusion by analysis of related literature under the guidance of the basic theory of traditional Chinese medicine (TCM)
and insidious phlegm could closely relate to the hyperlipidemia and inflammation. The interaction between the hyperlipidemia and inflammation in pathophysiological processes demonstrated pathogenic characteristics of the phlegm inducing blood stasis and phlegm-stasis blocking collaterals in TCM
that is basic cause leading to poor effects and prognosis of PCI. Thus
it is an important method to improve no-reflow or slow blood flow after PCI that applying treatment of boosting qi for resolving phlegm and promoting blood circulation for removing obstructionin collaterals. This method could combine multiple effects in pathological proecsses of myocardial ischemia reperfusion and delay the endpoint events
so that improve the quality of life and reduce mortality at maximun degree. There is no doubt that the effective methods of myocardial no-reflow prevention and treatment are well widen in clinical medicine of TCM
which has the certain directive meaning in clinically.
TCM Research of Theories and Prescriptions on Blood Glucose Fluctuation in Diabetes Mellitus: A Review
Treatment of Renal Hematuria with Traditional Chinese Medicine: A Review
Functioning Mechanism and Compatibility of Zhuye Shigaotang from Qi Circulation
Etiology and Pathogenesis of Hepatolenticular Degeneration Caused by Latent Toxin Blocking Collaterals
Related Author
XIE Chunguang
XIE Hongyan
ZHU Yongjiang
FU Xiaoxu
HAO Na
LIU Yang
GUO Luxuan
ZHAO Pengbo
Related Institution
Hospital of Chengdu University of TCM
Chengdu University of Traditional Chinese Medicine(TCM)
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin University of Traditional Chinese Medicine(TCM)